Article Sidebar

Download
View Article
Statistic
Read Counter : 30 Download : 52

Main Article Content

Abstract

The genomic sequencing of Monkeypox virus (MPXV) isolates has offered crucial insights into the virus's genetic variability and population biology. This review provides a concise summary of the current state of MPXV genetics and phylogenetics, with a particular emphasis on the potential of a broader dataset to improve molecular diagnostic methods and inform the development of antiviral medicines and diagnostic tests. The virus's evolutionary biology, particularly its interactions with natural reservoir hosts, can be better understood through the investigation of genetic data, precise outbreak identification, and improved surveillance. The genetic diversity among genotypes of monkeypox, a rare zoonotic infection with clinical manifestations similar to smallpox, significantly influences the severity of the disease and its transmission. The objective of this investigation is to enhance the genetic information on MPXV, evaluate the correlation between genotypic variations and disease outcomes, and investigate the manner in which these distinctions influence the pathogenesis of monkeypox. It is emphasized in the research that a multidisciplinary approach is crucial for the advancement of vaccine development, drug discovery, and the comprehension of virus-host interactions. The results underscore the necessity of ongoing genetic and serological surveillance to mitigate the obstacles presented by monkeypox and enhance public health responses.

Keywords

Monkeypox virus (MPXV), Genetic Variability, Phylogenetics, Molecular Diagnostics

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite
AL-Azzawi, M. K., Khlaif, S. M., & Zubaidi, N. A. (2024). Genetic Variability of Monkeypox Virus and Its Implications for Human Disease. International Journal Multidisciplinary (IJMI), 1(3), 104–125. https://doi.org/10.61796/ijmi.v1i3.180
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Berthet N, Descorps-Declère S, Besombes C, Curaudeau M, Nkili Meyong AA, Selekon B, et al. Genomic history of human monkey pox infections in the Central African Republic between 2001 and 2018. Sci Rep. 2021;11(1):13085.
  2. Senkevich TG, Yutin N, Wolf YI, Koonin E V, Moss B. Ancient gene capture and recent gene loss shape the evolution of orthopoxvirus-host interaction genes. MBio. 2021;12(4):10–1128.
  3. Daughton CG. Wastewater surveillance for population-wide Covid-19: The present and future. Sci Total Environ. 2020;736:139631.
  4. Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses. 2020;12(11):1257.
  5. Kumar N, Acharya A, Gendelman HE, Byrareddy SN. The 2022 outbreak and the pathobiology of the monkeypox virus. J Autoimmun. 2022;131:102855.
  6. Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox virus infection in humans across 16 countries—April–June 2022. N Engl J Med. 2022;387(8):679–91.
  7. Tarín-Vicente EJ, Alemany A, Agud-Dios M, Ubals M, Suñer C, Antón A, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet. 2022;400(10353):661–9.
  8. Ngabonziza JCS, Loiseau C, Marceau M, Jouet A, Menardo F, Tzfadia O, et al. A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region. Nat Commun. 2020;11(1):2917.
  9. Luna N, Muñoz M, Bonilla-Aldana DK, Patiño LH, Kasminskaya Y, Paniz-Mondolfi A, et al. Monkeypox virus (MPXV) genomics: a mutational and phylogenomic analyses of B. 1 lineages. Travel Med Infect Dis. 2023;52:102551.
  10. Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol. 2021;21(2):83–100.
  11. Melović B, Jocović M, Dabić M, Vulić TB, Dudic B. The impact of digital transformation and digital marketing on the brand promotion, positioning and electronic business in Montenegro. Technol Soc. 2020;63:101425.
  12. Ralph R, Lew J, Zeng T, Francis M, Xue B, Roux M, et al. 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness. J Infect Dev Ctries. 2020;14(01):3–17.
  13. Khosravi E, Keikha M. B. 1 as a new human monkeypox sublineage that linked with the monkeypox virus (MPXV) 2022 outbreak–correspondence. Int J Surg. 2022;105:106872.
  14. Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16(2):e0010141.
  15. Luna N, Ramírez AL, Muñoz M, Ballesteros N, Patiño LH, Castañeda SA, et al. Phylogenomic analysis of the monkeypox virus (MPXV) 2022 outbreak: Emergence of a novel viral lineage? Travel Med Infect Dis. 2022;49:102402.
  16. Simpson K, Heymann D, Brown CS, Edmunds WJ, Elsgaard J, Fine P, et al. Human monkeypox–After 40 years, an unintended consequence of smallpox eradication. Vaccine. 2020;38(33):5077–81.
  17. Li H, Zhang H, Ding K, Wang XH, Sun GY, Liu ZX, et al. The evolving epidemiology of monkeypox virus. Cytokine Growth Factor Rev. 2022;68:1–12.
  18. Kmiec D, Kirchhoff F. Monkeypox: a new threat? Int J Mol Sci. 2022;23(14):7866.
  19. Mitjà O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, et al. Monkeypox. Lancet. 2023;401(10370):60–74.
  20. Nguyen PY, Ajisegiri WS, Costantino V, Chughtai AA, MacIntyre CR. Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017–2020. Emerg Infect Dis. 2021;27(4):1007.
  21. Brennan G, Stoian AMM, Yu H, Rahman MJ, Banerjee S, Stroup JN, et al. Molecular mechanisms of poxvirus evolution. MBio. 2023;14(1):e01526-22.
  22. Mulkerrins KB (2023). CLCA the E of E faecalis. proquest. co. CRISPR Locus Combination Affects the Ecology of Enterococcus faecalis. University of Massachusetts Boston; 2023.
  23. Olson PD, Tracey A, Baillie A, James K, Doyle SR, Buddenborg SK, et al. Complete representation of a tapeworm genome reveals chromosomes capped by centromeres, necessitating a dual role in segregation and protection. BMC Biol. 2020;18:1–16.
  24. AL-Azzawi MK, Hasan NA, Barrak MM. A REVIEW OF THE DEVELOPMENT OF AN UNDERSTANDING OF ANTIBIOTIC INTERACTIONS, FROM MECHANISMS OF ACTION TO NOVEL RESISTANCE AND THE SEARCH FOR NATURAL ALTERNATIVES. Eur J Med Genet Clin Biol. 2024;1(6).
  25. Dutta D, Ghosh A, Dutta C, Sukla S, Biswas S. Cross‐reactivity of SARS‐CoV‐2 with other pathogens, especially dengue virus: A historical perspective. J Med Virol. 2023;95(2):e28557.
  26. Lu J, Xing H, Wang C, Tang M, Wu C, Ye F, et al. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. Signal Transduct Target Ther. 2023;8(1):458.
  27. Forni D, Cagliani R, Molteni C, Clerici M, Sironi M. Monkeypox virus: the changing facets of a zoonotic pathogen. Infect Genet Evol. 2022;105:105372.
  28. Wang L, Shang J, Weng S, Aliyari SR, Ji C, Cheng G, et al. Genomic annotation and molecular evolution of monkeypox virus outbreak in 2022. J Med Virol. 2023;95(1):e28036.
  29. Isidro J, Borges V, Pinto M, Sobral D, Santos JD, Nunes A, et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat Med. 2022;28(8):1569–72.
  30. Tsai K, Cullen BR. Epigenetic and epitranscriptomic regulation of viral replication. Nat Rev Microbiol. 2020;18(10):559–70.
  31. McBride AA. Human papillomaviruses: diversity, infection and host interactions. Nat Rev Microbiol. 2022;20(2):95–108.
  32. Sandbrink JB, Koblentz GD. Biosecurity risks associated with vaccine platform technologies. Vaccine. 2022;40(17):2514–23.
  33. Tiecco G, Degli Antoni M, Storti S, Tomasoni LR, Castelli F, Quiros-Roldan E. Monkeypox, a literature review: what is new and where does this concerning virus come from? Viruses. 2022;14(9):1894.
  34. Struzik J, Szulc-Dąbrowska L. NF-κB as an important factor in optimizing poxvirus-based vaccines against viral infections. Pathogens. 2020;9(12):1001.
  35. Sklenovská N. Monkeypox virus. In: Animal-origin viral zoonoses. Springer; 2020. p. 39–68.
  36. Meyer H, Ehmann R, Smith GL. Smallpox in the post-eradication era. Viruses. 2020;12(2):138.
  37. Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of respiratory viral infections. Annu Rev Virol. 2020;7(1):83–101.
  38. Nguyen TT, Pham TN, Van TD, Nguyen TT, Nguyen DTN, Le HNM, et al. Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam. PLoS One. 2020;15(11):e0242537.
  39. Ndodo N, Ashcroft J, Lewandowski K, Yinka-Ogunleye A, Chukwu C, Ahmad A, et al. Distinct monkeypox virus lineages co-circulating in humans before 2022. Nat Med. 2023;29(9):2317–24.
  40. Chakraborty C, Bhattacharya M, Sharma AR, Dhama K. Evolution, epidemiology, geographical distribution, and mutational landscape of newly emerging monkeypox virus. GeroScience. 2022;44(6):2895–911.
  41. Dopazo CP. The infectious pancreatic necrosis virus (IPNV) and its virulence determinants: What is known and what should be known. Pathogens. 2020;9(2):94.
  42. Varela K, Brown JA, Lipton B, Dunn J, Stanek D, Consultants NC, et al. A review of zoonotic disease threats to pet owners: A compendium of measures to prevent zoonotic diseases associated with non-traditional pets such as rodents and other small mammals, reptiles, amphibians, backyard poultry, and other selected animals. Vector-Borne Zoonotic Dis. 2022;22(6):303–60.
  43. Karia R, Gupta I, Khandait H, Yadav A, Yadav A. COVID-19 and its modes of transmission. SN Compr Clin Med. 2020;2(10):1798–801.
  44. Endo A, Murayama H, Abbott S, Ratnayake R, Pearson CAB, Edmunds WJ, et al. Heavy-tailed sexual contact networks and monkeypox epidemiology in the global outbreak, 2022. Science (80- ). 2022;378(6615):90–4.
  45. Montenegro de Wit M. What grows from a pandemic? Toward an abolitionist agroecology. J Peasant Stud. 2021;48(1):99–136.
  46. Singhal T, Kabra SK, Lodha R. Monkeypox: a review. Indian J Pediatr. 2022;89(10):955–60.
  47. Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, AlRubaish AA, Mahmoud A, et al. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. J Infect Public Health. 2023;16(4):531–41.
  48. Damon IK. Poxviruses. Man Clin Microbiol. 2011;1647–58.
  49. Pan D, Nazareth J, Sze S, Martin CA, Decker J, Fletcher E, et al. Transmission of monkeypox/mpox virus: a narrative review of environmental, viral, host, and population factors in relation to the 2022 international outbreak. J Med Virol. 2023;95(2):e28534.
  50. Farahat RA, Sah R, El-Sakka AA, Benmelouka AY, Kundu M, Labieb F, et al. Human monkeypox disease (MPX). Le Infez Med. 2022;30(3):372.
  51. Mauldin MR, McCollum AM, Nakazawa YJ, Mandra A, Whitehouse ER, Davidson W, et al. Exportation of monkeypox virus from the African continent. J Infect Dis. 2022;225(8):1367–76.
  52. Altindis M, Puca E, Shapo L. Diagnosis of monkeypox virus–An overview. Travel Med Infect Dis. 2022;50:102459.
  53. Estrada A, Garber PA. Principal drivers and conservation solutions to the impending primate extinction crisis: Introduction to the special issue. Int J Primatol. 2022;43(1):1–14.
  54. Xiang Y, White A. Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters. Emerg Microbes Infect. 2022;11(1):1768–77.
  55. Patel M, Adnan M, Aldarhami A, Bazaid AS, Saeedi NH, Alkayyal AA, et al. Current insights into diagnosis, prevention strategies, treatment, therapeutic targets, and challenges of monkeypox (Mpox) infections in human populations. Life. 2023;13(1):249.
  56. Facciuolo A, Denomy C, Lipsit S, Kusalik A, Napper S. From beef to bees: High-throughput kinome analysis to understand host responses of livestock species to infectious diseases and industry-associated stress. Front Immunol. 2020;11:765.
  57. Shang S, Zhuang K, Chen J, Zhang M, Jiang S, Li W. A bioactive composite hydrogel dressing that promotes healing of both acute and chronic diabetic skin wounds. Bioact Mater. 2024;34:298–310.
  58. Wang CC, Prather KA, Sznitman J, Jimenez JL, Lakdawala SS, Tufekci Z, et al. Airborne transmission of respiratory viruses. Science (80- ). 2021;373(6558):eabd9149.
  59. Gong Q, Wang C, Chuai X, Chiu S. Monkeypox virus: a re-emergent threat to humans. Virol Sin. 2022;37(4):477–82.
  60. Peacock TP, Penrice-Randal R, Hiscox JA, Barclay WS. SARS-CoV-2 one year on: evidence for ongoing viral adaptation. J Gen Virol. 2021;102(4):1584.
  61. Doshi RH, Alfonso VH, Morier D, Hoff NA, Sinai C, Mulembakani P, et al. Monkeypox rash severity and animal exposures in the Democratic Republic of the Congo. Ecohealth. 2020;17:64–73.
  62. Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022;22(8):1153–62.
  63. Weng LM, Su X, Wang XQ. Pain symptoms in patients with coronavirus disease (COVID-19): a literature review. J Pain Res. 2021;147–59.
  64. Bryer J, Freeman EE, Rosenbach M. Monkeypox emerges on a global scale: a historical review and dermatologic primer. J Am Acad Dermatol. 2022;87(5):1069–74.
  65. Guarner J, Del Rio C, Malani PN. Monkeypox in 2022—what clinicians need to know. Jama. 2022;328(2):139–40.
  66. Shafaati M, Zandi M. Monkeypox virus neurological manifestations in comparison to other orthopoxviruses. Travel Med Infect Dis. 2022;49:102414.
  67. Vasala A, Hytönen VP, Laitinen OH. Modern tools for rapid diagnostics of antimicrobial resistance. Front Cell Infect Microbiol. 2020;10:308.
  68. Zhang N, Wang L, Deng X, Liang R, Su M, He C, et al. Recent advances in the detection of respiratory virus infection in humans. J Med Virol. 2020;92(4):408–17.
  69. Jaiswal V, Nain P, Mukherjee D, Joshi A, Savaliya M, Ishak A, et al. Symptomatology, prognosis, and clinical findings of Monkeypox infected patients during COVID‐19 era: A systematic‐review. Immunity, Inflamm Dis. 2022;10(11):e722.
  70. Grifoni A, Zhang Y, Tarke A, Sidney J, Rubiro P, Reina-Campos M, et al. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans. Cell Host Microbe. 2022;30(12):1662–70.
  71. Mukherjee AG, Wanjari UR, Kannampuzha S, Das S, Murali R, Namachivayam A, et al. Expression of Concern: The pathophysiological and immunological background of the monkeypox virus infection: An update. J Med Virol. 2023;95(1):e28206.
  72. Lozano-Rodríguez R, Valentín-Quiroga J, Avendaño-Ortiz J, Martín-Quirós A, Pascual-Iglesias A, Terrón-Arcos V, et al. Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19. Cell Rep. 2022;38(2).
  73. Juan-Giner A, Kimathi D, Grantz KH, Hamaluba M, Kazooba P, Njuguna P, et al. Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial. Lancet. 2021;397(10269):119–27.
  74. Collier JL, Weiss SA, Pauken KE, Sen DR, Sharpe AH. Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity. Nat Immunol. 2021;22(7):809–19.
  75. Low JS, Vaqueirinho D, Mele F, Foglierini M, Jerak J, Perotti M, et al. Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2. Science (80- ). 2021;372(6548):1336–41.
  76. Hasan S, Saeed S. Monkeypox disease: an emerging public health concern in the shadow of COVID-19 pandemic: an update. Trop Med Infect Dis. 2022;7(10):283.
  77. Yang Z, Gray M, Winter L. Why do poxviruses still matter? Cell Biosci. 2021;11(1):96.
  78. Li H, Huang QZ, Zhang H, Liu ZX, Chen XH, Ye LL, et al. The land-scape of immune response to monkeypox virus. EBioMedicine. 2023;87.
  79. Koehler HS, Jacobs BL. Subversion of programed cell death by poxviruses. In: Alternate Programmed Cell Death Signaling in Antiviral Host Defense. Springer; 2021. p. 105–31.
  80. Thoms D, Liang Y, Haney CH. Maintaining symbiotic homeostasis: how do plants engage with beneficial microorganisms while at the same time restricting pathogens? Mol Plant-Microbe Interact. 2021;34(5):462–9.
  81. Clever S, Volz A. Mouse models in COVID-19 research: analyzing the adaptive immune response. Med Microbiol Immunol. 2023;212(2):165–83.
  82. Liu R, Americo JL, Cotter CA, Earl PL, Erez N, Peng C, et al. One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection. Proc Natl Acad Sci. 2021;118(12):e2026785118.
  83. De Groot AS, Moise L, Terry F, Gutierrez AH, Hindocha P, Richard G, et al. Better epitope discovery, precision immune engineering, and accelerated vaccine design using immunoinformatics tools. Front Immunol. 2020;11:442.
  84. Bukar AM, Jesse FFA, Abdullah CAC, Noordin MM, Lawan Z, Mangga HK, et al. Immunomodulatory strategies for parapoxvirus: current status and future approaches for the development of vaccines against Orf virus infection. Vaccines. 2021;9(11):1341.
  85. Pelin A, Boulton S, Tamming LA, Bell JC, Singaravelu R. Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity. Expert Opin Biol Ther. 2020;20(9):1083–97.
  86. Paludan SR, Pradeu T, Masters SL, Mogensen TH. Constitutive immune mechanisms: mediators of host defence and immune regulation. Nat Rev Immunol. 2021;21(3):137–50.
  87. Sajjad Jawad Kadhim1 Salam Mohammed Khlaif3, Mustafa Kareem AL-Azzawi4, Nabaa Abbas Zubaidi5 MAS. EVALUATING THE IMPACT OF ENDOCRINE-DISRUPTING CHEMICALS ON FERTILITY IN WILDLIFE: FROM AMPHIBIANS TO MAMMALS. J Med Genet Clin Biol. 2024;1(2024 | 8):216–28.
  88. Mpakali A, Stratikos E. The role of antigen processing and presentation in cancer and the efficacy of immune checkpoint inhibitor immunotherapy. Cancers (Basel). 2021;13(1):134.
  89. Adnan N, ul Haq Z, Malik A, Mehmood A, Ishaq U, Faraz M, et al. Human monkeypox virus: An updated review. Medicine (Baltimore). 2022;101(35):e30406.
  90. Disis MLN, Guthrie KA, Liu Y, Coveler AL, Higgins DM, Childs JS, et al. Safety and outcomes of a plasmid DNA vaccine encoding the ERBB2 intracellular domain in patients with advanced-stage ERBB2-positive breast cancer: a phase 1 nonrandomized clinical trial. JAMA Oncol. 2023;9(1):71–8.
  91. Meganck RM, Baric RS. Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases. Nat Med. 2021;27(3):401–10.
  92. Taube JC, Rest EC, Lloyd-Smith JO, Bansal S. The global landscape of smallpox vaccination history and implications for current and future orthopoxvirus susceptibility: a modelling study. Lancet Infect Dis. 2023;23(4):454–62.
  93. Agrawal U, Katikireddi SV, McCowan C, Mulholland RH, Azcoaga-Lorenzo A, Amele S, et al. COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2· 57 million people in Scotland (EAVE II): a prospective cohort study. Lancet Respir Med. 2021;9(12):1439–49.
  94. Kamboj M, Bohlke K, Baptiste DM, Dunleavy K, Fueger A, Jones L, et al. Vaccination of adults with cancer: ASCO guideline. J Clin Oncol. 2024;42(14):1699–721.
  95. Priyamvada L, Carson WC, Ortega E, Navarra T, Tran S, Smith TG, et al. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo. Vaccine. 2022;40(50):7321–7.
  96. Fang C, Xiao G, Wang T, Song L, Peng B, Xu B, et al. Emerging nano-/biotechnology drives oncolytic virus-activated and combined cancer immunotherapy. Research. 2023;6:108.
  97. Cookenham T, Lanzer KG, Gage E, Lorenzo EC, Carter D, Coler RN, et al. Vaccination of aged mice with adjuvanted recombinant influenza nucleoprotein enhances protective immunity. Vaccine. 2020;38(33):5256–67.
  98. Rühl J, Leung CS, Münz C. Vaccination against the Epstein–Barr virus. Cell Mol Life Sci. 2020;77:4315–24.
  99. Sharma L, Chandrasekaran A, Bendoly E. Does the office of patient experience matter in improving delivery of care? Prod Oper Manag. 2020;29(4):833–55.
  100. Saadh MJ, Ghadimkhani T, Soltani N, Abbassioun A, Pecho RDC, Kazem TJ, et al. Progress and prospects on vaccine development against monkeypox infection. Microb Pathog. 2023;180:106156.
  101. Harvey E, Holmes EC. Diversity and evolution of the animal virome. Nat Rev Microbiol. 2022;20(6):321–34.
  102. Lawrence MG, Williams S, Nanz P, Renn O. Characteristics, potentials, and challenges of transdisciplinary research. One Earth. 2022;5(1):44–61.
  103. Tambo E, Al-Nazawi AM. Combating the global spread of poverty-related Monkeypox outbreaks and beyond. Infect Dis Poverty. 2022;11(1):80.
  104. Assessment RR. Monkeypox multi-country outbreak. Eur Cent Dis Prev Control. 2022;
  105. Saied AA, Dhawan M, Metwally AA, Fahrni ML, Choudhary P, Choudhary OP. Disease history, pathogenesis, diagnostics, and therapeutics for human monkeypox disease: a comprehensive review. Vaccines. 2022;10(12):2091.
  106. Han BA, O’Regan SM, Paul Schmidt J, Drake JM. Integrating data mining and transmission theory in the ecology of infectious diseases. Ecol Lett. 2020;23(8):1178–88.
  107. QASIM MK, AL-SAADI ZN, ALI JF. Phenotypic and Genotypic Identification, Antibiogram of MRSA Isolated from Patients in Wasit city. Int J Pharm Res. 2020;
  108. Jehanne Q, Pascoe B, Bénéjat L, Ducournau A, Buissonnière A, Mourkas E, et al. Genome-wide identification of host-segregating single-nucleotide polymorphisms for source attribution of clinical Campylobacter coli isolates. Appl Environ Microbiol. 2020;86(24):e01787-20.
  109. Jung M, Arnell A, De Lamo X, García-Rangel S, Lewis M, Mark J, et al. Areas of global importance for conserving terrestrial biodiversity, carbon and water. Nat Ecol Evol. 2021;5(11):1499–509.